COMP and ovarian cancer: Transwell migration assays indicated that COMP-induced migration was significantly reduced by DAPT (10 μM; Fig. 5A–C) and the anti-Jagged1 antibody (5 μg/ml) in both ovarian cancer cell lines (Fig. 5D–F).